middle.news
Monash IVF Navigates FY25 Growth Amid Clinical Challenges and Leadership Shift
9:58pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
Monash IVF Navigates FY25 Growth Amid Clinical Challenges and Leadership Shift
9:58pm on Friday 29th of August, 2025 AEST
Key Points
FY25 underlying NPAT of $27.4 million, matching updated guidance
Revenue rose 6.7% to $271.9 million; EBITDA grew 5.6% to $66.3 million
Domestic stimulated cycles declined 5%, international down 6.4% due to macro factors
Major infrastructure upgrades nearing completion, including new Brisbane clinic
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Monash Ivf (ASX:MVF)
OPEN ARTICLE